Skip to content

Efficacy of Homoeopathy in Rheumatoid Arthritis

To study the homoeopathic approach in cases of Rheumatoid Arthritis with miasmatic evaluation - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072461
Enrollment
40
Registered
2024-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

Intervention1: INDIVIDUALISD HOMOEOPATHIC MEDICINE: An Individualised Homoeopathic Medicine Will be Administered To Patient Through Oral Route Potency :- 30, 200, 1m, 10m as per the susceptibility of

Sponsors

Dr Jhanvi Padariya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both male and female are included. 2. 30-65 years of age groups are included. 3. Patient who are voluntarily taking Homoeopathic Medicines. 4. Patient who has Rheumatoid Factor or Anti-CCP positive.

Exclusion criteria

Exclusion criteria: 1. Age below 30 and above 65 years. 2. Patient having destruction of joints and cartilage and need for Total Knee Replacement. 3. Patient having Extra-articular feature of Rheumatoid arthritis like Cardiac and pulmonary involvement. ? Patient having terminal disease like Cancer, HIV.

Design outcomes

Primary

MeasureTime frame
To assess the importance of miasmatic analysis in the cases of Rheumatoid Arthritis which are diagnosed and assessed with DAS 28 score as response criteria for effective assessment.Timepoint: It will be achieved within 09 months of the completion of study thereafter statistical assessment will be done

Secondary

MeasureTime frame
1. To assess the correlation of miasm in cases of Rheumatoid Arthritis. 2. To ascertain the role of Homoeopathic Medicines in the cases of Rheumatoid Arthritis. 3. To reduce complications of disease by effectiveness of Homoeopathic medicines.Timepoint: It will be achieved within 09 months of the completion of study alongwith primary outcome thereafter statistical assessment will be done

Countries

India

Contacts

Public ContactDr Jhanvi Padariya

Rajkot Homoeopathic Medical College

bhusan.rajgururhmc@paruluniversity.ac.in9824514981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026